Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

A man regrew hair after using a specific cream for skin treatment.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Apremilast did not work for treating severe alopecia areata.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Further trials are needed to explore the efficacy of triamcinolone acetonide in dermatology.

Retinoic acid is effective for treating eruptive vellus hair cysts.

Zinc supplements can help skin issues even if blood zinc levels are normal.

Early genetic testing and zinc therapy are crucial for managing acrodermatitis enteropathica effectively.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

A patient experienced long-lasting hair loss after using acitretin for psoriasis.

Most antiandrogen treatments effectively reduce acne in hyperandrogenic women, but finasteride is the least effective.

Antimicrobial therapy can help manage Folliculitis Decalvans.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Low-dose isotretinoin and erythromycin effectively treated hair loss in two young sisters.

New acne treatments show promise as alternatives to traditional therapies.

The study found that family history, personal history of adolescent acne, no pregnancies, hirsutism, office work, stress, and low intake of fruits/vegetables and fish are risk factors for adult female acne.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Acneiform follicular mucinosis can be controlled with systemic corticosteroids.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.